TITLE

Size and dynamics of order-of-entry effects in pharmaceutical markets

AUTHOR(S)
Porath, Daniel
PUB. DATE
January 2018
SOURCE
International Journal of Market Research;Jan2018, Vol. 60 Issue 1, p50
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In anticipation of long-run competitive advantages, pharmaceutical companies often try to enter new markets earlier than their competitors. It is questionable, however, whether this effort is really justified, because knowledge about the expected size of these order-of-entry advantages is scarce. Apart from confirming the existence of long-run advantages for the first mover for some selected brands, the literature gives hardly any guidelines. The objective of this article is to provide the information on the existence, the size, and the dynamics of order-of-entry effects, which is necessary for deciding on the optimal moment for a launch. The author proposes a new framework--a fractional panel probit model--which is fitted to a big and representative sample. With this procedure, order-of-entry effects can be measured in a multivariate model and as absolute market share differences, which is more informative for pharmaceutical companies than former measures.
ACCESSION #
127887427

 

Related Articles

  • Entry Order and Its Relationship to Market Share and Competitive Advantage: A Study of New Corporate Ventures. Miller, Alex; Gartner, William B.; Wilson, Robert // Academy of Management Best Papers Proceedings;1988, p64 

    Building on previous conceptual and empirical research, hypotheses about the effects of entry order on market share and competitive advantage are offered. An analysis of 119 new corporate ventures in the Strategic Planning Institute's STRA database found that early entrants achieved superior...

  • CONSTRUCTING MARKETS AND ORGANIZING BOUNDARIES: ENTREPRENEURIAL ACTION IN NASCENT FIELDS. SANTOS, FILIPE M.; EISENHARDT, KATHLEEN M. // Academy of Management Proceedings;2004, pJ1 

    This article discusses how executives in entrepreneurial firms addressing nascent markets organize the boundaries of their firms. Entrepreneurs need to establish themselves in an initial market, but do not usually have a strong resource base nor established competencies to leverage. By...

  • Network Competition and Entry Deterrence. Calzada, Joan; Valletti, Tommaso M. // Economic Journal;Aug2008, Vol. 118 Issue 531, p1223 

    We develop a model of logit demand that extends the traditional duopoly framework of network competition to a multi-firm industry. First, we show that incumbents establish the reciprocal access charge inefficiently below cost when they compete in prices but they behave efficiently if they...

  • Summary Brief: Entry Timing and Firm Survival in Technology Evolutionary Environment. Ya You // Society for Marketing Advances Proceedings;2010, p102 

    This study examines the relationship between entry timing and firm survival in a technology evolutionary context. I suggest that the relationship is moderated by the two components of technology intensity and the pace of technological growth in a technology evolutionary environment. Using a...

  • WHO FOLLOWS WHOM? ASYMMETRIC COMPETITION IN CROSS-BORDER MARKET EXPANSION. HSIEH, KAI-YU; CHEN, MING-JER // Academy of Management Annual Meeting Proceedings;2009, Vol. 2009 Issue 1, p1 

    The article examines the competitive relationships between companies in the same industry and from the same home country. It looks at how a company's asymmetric relationship with a competitor impacts its behavior in engaging this competitor oversees. Topics include cross-border competition,...

  • The use of combined conjoint approaches to improve market share predictions. Bowditch, Allan; Gurrieri, Gustavo; Henry, Beverley // International Journal of Market Research;2003 Quarter 3, Vol. 45 Issue 3, p389 

    Within the pharmaceutical prescription sector, just like many other markets, maintaining competitive advantage has become increasingly difficult. In the healthcare arena, the period of time that a new chemical entity has on the market before a key competitor emerges has been significantly...

  • Competitive Landscape.  // U.S. Pharma & Healthcare Report;Q1 2009, p79 

    The article examines factors affecting competition in the global pharmaceutical industry as of the first quarter of 2009. Exchange rates are expected to present a particular problem for the industry due to the regulated nature of many markets. U.S.-based Pfizer is considered the largest...

  • Fine Chemicals. Scott, Alex // Chemical Week;2/15/2006, Vol. 168 Issue 6, p27 

    The article deals with the entry of Indian custom fine chemical contract manufacturing organizations in the active pharmaceutical ingredient (API) sector in February 2006. The organizations are no longer satisfied with increasing their share of the pharmaceutical intermediates market and have...

  • LETTING RIVALS COME CLOSE OR WARDING THEM OFF? THE EFFECTS OF SUBSTITUTION THREAT ON IMITATION DETERRENCE. Polidoro Jr., Francisco; Puay Khoon Toh // Academy of Management Journal;Apr2011, Vol. 54 Issue 2, p369 

    A resource-based theory postulate is that firms must defend their resources against imitation to sustain competitive advantage. However, by deterring imitation, firms may induce rivals to create substitutes. This study shows that, contrary to received wisdom, firms are not uniformly inclined to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics